Molina Healthcare, Inc. (NYSE:MOH) Receives Consensus Rating of “Hold” from Analysts

Molina Healthcare, Inc. (NYSE:MOH) has been assigned a consensus rating of “Hold” from the thirteen analysts that are currently covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, six have given a hold rating, five have issued a buy rating and one has issued a strong buy rating on the company. The average twelve-month price target among analysts that have issued a report on the stock in the last year is $378.00.

Several analysts have commented on MOH shares. Stephens reiterated an “equal weight” rating and set a $320.00 target price on shares of Molina Healthcare in a research report on Thursday, July 25th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $406.00 price objective on shares of Molina Healthcare in a research report on Tuesday, October 1st. Truist Financial dropped their target price on shares of Molina Healthcare from $440.00 to $400.00 and set a “buy” rating on the stock in a report on Monday, July 15th. Deutsche Bank Aktiengesellschaft reduced their price target on shares of Molina Healthcare from $354.00 to $353.00 and set a “hold” rating for the company in a report on Monday, July 29th. Finally, JPMorgan Chase & Co. cut their price objective on shares of Molina Healthcare from $420.00 to $395.00 and set an “overweight” rating on the stock in a research report on Wednesday, July 10th.

Insider Transactions at Molina Healthcare

In related news, Director Steven J. Orlando sold 1,000 shares of Molina Healthcare stock in a transaction dated Tuesday, July 30th. The stock was sold at an average price of $339.21, for a total value of $339,210.00. Following the sale, the director now owns 18,025 shares of the company’s stock, valued at approximately $6,114,260.25. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, Director Steven J. Orlando sold 1,000 shares of the firm’s stock in a transaction on Tuesday, July 30th. The shares were sold at an average price of $339.21, for a total value of $339,210.00. Following the completion of the transaction, the director now directly owns 18,025 shares of the company’s stock, valued at approximately $6,114,260.25. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CAO Maurice Hebert sold 393 shares of the business’s stock in a transaction on Thursday, August 15th. The stock was sold at an average price of $346.52, for a total transaction of $136,182.36. Following the transaction, the chief accounting officer now owns 9,473 shares in the company, valued at approximately $3,282,583.96. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 1.10% of the company’s stock.

Institutional Investors Weigh In On Molina Healthcare

Hedge funds have recently bought and sold shares of the company. Wellington Management Group LLP raised its stake in Molina Healthcare by 12.8% in the fourth quarter. Wellington Management Group LLP now owns 3,831,100 shares of the company’s stock valued at $1,384,215,000 after buying an additional 436,060 shares during the period. Swedbank AB bought a new stake in Molina Healthcare in the 1st quarter valued at $69,320,000. Jupiter Asset Management Ltd. raised its stake in Molina Healthcare by 434.6% in the 2nd quarter. Jupiter Asset Management Ltd. now owns 185,606 shares of the company’s stock valued at $55,181,000 after acquiring an additional 150,890 shares during the period. AQR Capital Management LLC lifted its holdings in Molina Healthcare by 36.2% during the 2nd quarter. AQR Capital Management LLC now owns 463,537 shares of the company’s stock valued at $137,810,000 after purchasing an additional 123,121 shares during the last quarter. Finally, Renaissance Technologies LLC boosted its position in Molina Healthcare by 13.3% during the second quarter. Renaissance Technologies LLC now owns 949,691 shares of the company’s stock worth $282,343,000 after purchasing an additional 111,154 shares during the period. 98.50% of the stock is currently owned by institutional investors and hedge funds.

Molina Healthcare Stock Performance

Shares of Molina Healthcare stock opened at $331.00 on Friday. The company has a debt-to-equity ratio of 0.49, a current ratio of 1.57 and a quick ratio of 1.57. The firm has a 50 day simple moving average of $341.59 and a 200 day simple moving average of $333.97. Molina Healthcare has a fifty-two week low of $282.96 and a fifty-two week high of $423.92. The firm has a market cap of $19.40 billion, a P/E ratio of 17.96, a P/E/G ratio of 1.15 and a beta of 0.58.

Molina Healthcare (NYSE:MOH) last released its earnings results on Wednesday, July 24th. The company reported $5.86 EPS for the quarter, beating the consensus estimate of $5.73 by $0.13. The company had revenue of $9.88 billion during the quarter, compared to analysts’ expectations of $9.75 billion. Molina Healthcare had a return on equity of 28.09% and a net margin of 2.84%. The business’s revenue for the quarter was up 18.7% on a year-over-year basis. During the same period last year, the firm earned $5.65 EPS. Sell-side analysts predict that Molina Healthcare will post 23.5 earnings per share for the current fiscal year.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.